For individuals living with Transthyretin Amyloid Cardiomyopathy (ATTR-CM), a debilitating condition, the arrival of this treatment and Attruby represents a genuine breakthrough . These groundbreaking therapies protect the transthyretin protein, halting its damaging build-up and lessening the severity of the disease . Individuals are now seeing … Read More